•  
  •  
  •  
  •  

2026-07-25 18:21:34

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • SKP Securities Reports Q1 FY27 Net Profit of ₹2.24 Crore; Revenue From Operations Stands at ₹10.43 Crore
  • Nila Infrastructures Reports Q1 FY27 Consolidated Results: Net Profit Rises 25.8% YoY to ₹8.44 Crore
  • Surana Solar Reports Surge in Q1 FY27 Net Profit to ₹5.44 Crore Driven by Higher Other Income and Revenue Growth
  • Dodla Dairy Acquires Strategic 2% Stake in Direct-to-Consumer Brand Sids Farm for ₹11.65 Crore
  • Neueon Corporation Secures ₹150 Crore Orders from Elcom Innovations for Tactical Communication Equipment

Keywords Selected:  DivisLaboratories

Stock Report

  • USFDA inspects Unit 1 of Divi's Laboratories Limited
  • Divis Laboratories Ltd posts consolidated Q1FY26 PAT of Rs. 545 crores
  • Divi's Laboratories inks long term manufacturing and supply agreement with global pharma company
  • Divi's Laboratories Limited recommends final dividend of Rs. 30
  • Divi's Laboratories Ltd reports higher consolidated PAT of Rs. 662 crores
  • Divi's Laboratories signs long-term manufacturing and supply agreement with global pharma company
  • Divis Laboratories Ltd posts consolidated PAT of Rs. 430 crores in Q1FY25
  • USFDA completes cGMP inspection of Divi's Laboratories Limited's Unit 2
  • Divi's Laboratories Ltd to expand capacity at an outlay of Rs. 650 to Rs. 700 crores
  • Divis Laboratories Ltd posts Rs. 348 crores consolidated net profit in Q2 FY2024
  • USFDA Delegation visits Divi's Laboratories Limited's Unit I at Choutuppal, Telangana, India
  • Divi's Laboratories Limited recommends dividend of Rs. 30
  • Divi's Laboratories Limited Q4FY23 consolidated PAT marginally up QoQ at Rs. 320.97 crores
  • Divi's Laboratories Selects Juniper Networks for Automated Network Infrastructure Across Massive Pharma Manufacturing Facilities
  • Divis Laboratories Ltd posts consolidated Q3FY23 PAT of Rs. 306.80 crores
  • Divis Laboratories Ltd Q2 FY2023 consolidated profit declines to Rs. 493.60 crores
  • Divis Laboratories Ltd reports consolidated PAT of Rs. 702.01 crores in Q1 FY2023
  • Divi's Laboratories Ltd recommends dividend of Rs. 30
  • Divi's Laboratories Q4FY22 consolidated PAT slips QoQ to Rs. 894.64 crores
  • Divis Laboratories Ltd consolidated Q3FY22 PAT zooms to Rs. 902.24 crores
  • Divis Laboratories Ltd consolidated Q2FY22 PAT up at Rs. 606.46 crore

Latest Post

  • SKP Securities Reports Q1 FY27 Net Profit of ₹2.24 Crore; Revenue From Operations Stands at ₹10.43 Crore
  • Nila Infrastructures Reports Q1 FY27 Consolidated Results: Net Profit Rises 25.8% YoY to ₹8.44 Crore
  • Surana Solar Reports Surge in Q1 FY27 Net Profit to ₹5.44 Crore Driven by Higher Other Income and Revenue Growth
  • Dodla Dairy Acquires Strategic 2% Stake in Direct-to-Consumer Brand Sids Farm for ₹11.65 Crore
  • Neueon Corporation Secures ₹150 Crore Orders from Elcom Innovations for Tactical Communication Equipment


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025